期刊文献+

血小板输注无效列线图预测模型的构建 被引量:10

Construction of the nomogram model for predicting platelet transfusion refractoriness
在线阅读 下载PDF
导出
摘要 目的:构建并验证血小板输注无效的列线图模型。方法:选取2019年1月至12月于温州医科大学附属第二医院育英儿童医院收治的174例血小板输注患者,其中46例血小板输注无效,128例血小板输注有效,收集患者临床资料,包括年龄、性别、多次妊娠、活动性出血、皮肤黏膜出血、脾肿大、发热、ABO血型、输注血小板次数、血小板抗体和血小板计数。采用单因素、多因素Logistic回归分析探讨血小板输注无效的危险因素,构建列线图,并进行验证。结果:多因素Logistic回归分析结果显示:女性(OR=2.43,95%CI=1.08~5.44,P=0.031)、血小板抗体阳性(OR=4.46,95%CI=1.11~17.85,P=0.035)、发热(OR=2.42,95%CI=1.03~5.71,P=0.042)、脾肿大(OR=2.14,95%CI=1.01~5.92,P=0.045)、输注血小板3次以上(OR=4.90,95%CI=2.10~11.42,P=0.002)是血小板输注无效的危险因素,由此建立列线图模型。模型经内部验证(Bootstrap重抽样500次)后,预测血小板输注无效的ROC曲线下面积为0.858。结论:本研究构建的血小板输注无效列线图预测模型准确性良好,有良好的校准度与区分度。 Objective:To construct and validate a nomogram that can be used to predict platelet transfusion refractoriness in patients who received platelet transfusions.Methods:A total of 174 patients who received platelet transfusions were selected from the Second Affiliated Hospital&Yuying Children’s Hospital of Wenzhou Medical University from January 2019 to December 2019.Among 174 patients,46(26.4%)were platelet transfusion refractoriness.Pertinent clinical data were collected including patient age,gender,multiple pregnancies,active bleeding,skin and mucous membrane bleeding,splenomegaly,fever,ABO blood group,number of platelet transfusions,platelet antibody and platelet count.Multivariate logistic regression was used to screen independent factors and to construct the nomogram.Results:Multivariate logistic regression indicated that female(OR=2.43,95%CI=1.08-5.44,P=0.0310),platelet antibody(OR=4.46,95%CI=1.11-17.85,P=0.035),infection(OR=2.42,95%CI=1.03-5.71,P=0.042),splenomegaly(OR=2.14,95%CI=1.01-5.92,P=0.045),infusion times(OR=4.90,95%CI=2.10-11.42,P=0.002)were associated with higher odds of platelet transfusion refractoriness.Afterwards,the above variables were incorporated into the nomogram.Bootstrap test(Bootstrap resampling times=500),used for internal validation,revealed that the AUC was 0.858.Conclusion:The constructed nomogram could potentially predict platelet transfusion refractoriness in patients who received platelet transfusion.
作者 苏高繁 陈静思 郑婷婷 金方思 江明华 SU Gaofan;CHEN Jingsi;ZHENG Tingting;JIN Fangsi;JIANG Minghua(Department of Blood Transfusion,the Second Affiliated Hospital&Yuying Children’s Hospital of Wenzhou Medical University,Wenzhou 325027,China;Department of Clinical Laboratory,the Second Affiliated Hospital&Yuying Children’s Hospital of Wenzhou Medical University,Wenzhou 325027,China)
出处 《温州医科大学学报》 2021年第9期741-745,共5页 Journal of Wenzhou Medical University
关键词 血小板输注无效 危险因素 列线图模型 platelet transfusion refractoriness risk factors nomogram model
作者简介 苏高繁,技师,Email:447284204@qq.com。;通信作者:江明华,主任技师,Email:minghua93@126.com。
  • 相关文献

参考文献3

二级参考文献23

  • 1British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions[J]. Br J Haematol, 2003,122 : 10- 23.
  • 2TINMOUTH A T, SEMPLE E, SHEHATA N, et al. Platelet immunopathology and therapy: a Canadian Blood Services Research and Development Symposium[J]. Transfus Med Rev,2006,20: 294-314.
  • 3BRUBAKER D B, MARCUS C, HOLMES E. Intravascular and total body platelet equilibrium in healthy volunteers and in thrombocytopenic patients transfused with single donor platelets[J]. Am J Hematol. 1998,58:165-176.
  • 4SLICHTER S J,DAVIS K,ENRIGHT H,et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients[J]. Blood, 2005, 105: 4106-4114.
  • 5SEMPLE JW, ASLAM R, KIM M, et al. Plateletbound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets [J]. Blood,2007,109 : 4803-4805.
  • 6PETZ L D,GARRATTY G,CALHOUN L,et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity[J]. Transfusion, 2000,40 : 1446 - 1456.
  • 7ASTER R H, BOUGIE D W. Drug-induced immune thrombocytopenia[J]. New Eng J Med, 2007, 357: 580-587.
  • 8KOSUGI S, TOM, IYAMA Y, HONDA S, et al. Platelet-associated anti-GPⅡb-Ⅲa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand--inding site of glycoprotein (GP) Ⅱb[J]. Blood, 2001, 98: 1819-1827.
  • 9BOYLAN B, CHEN H, RATHORE V, et al. Anti- GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma chain complex from the human platelet surface[J]. Blood, 2004,104 : 1350-1355.
  • 10LUBENKO A,RODI KM,JOHNSON A C. Screening for WBC antibodies by lymphocyte indirect immunofluorescence flow cytometry: superior to cytotoxicity and ELISA[J]? Transfusion, 2001,41 : 1147 -1153.

共引文献23

同被引文献89

引证文献10

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部